Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent Split Virion Influenza Vaccine vs Trivalent Vaccines in ≥6-Month-Old Subjects
CTR20191861Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of quadrivalent inactivated split virion influenza vaccine in influenza, sponsored by Sanofi. Started Oct 2019; status: completed.
02
Drugs
quadrivalent inactivated split virion influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20191861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191861.